Abbott (ABT) Looks Good: Stock Adds 7.9% in Session

Abbott Laboratories ABT was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $99.06 to $103.19 in the past one-month time frame.

The upmove came after Abbott's BinaxNOW COVID-19 Ag Card rapid test received FDA Emergency Use Authorization.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Abbott currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Abbott Laboratories Price

Abbott Laboratories price | Abbott Laboratories Quote

Investors interested in the Medical - Products sector may consider Surface Oncology Inc SURF, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q2 2020, while the S&P 500 gained an impressive +44.0%, five of our strategies returned +50.9%, +93.8%, +122.2%, +153.0%, and even +156.8%.

This outperformance has not just been a recent phenomenon. From 2000 – Q2 2020, while the S&P averaged +5.5% per year, our top strategies averaged up to +51.7% per year.

See their latest picks free >>

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.